Pharmaceutical Executive®
@pharmexec.bsky.social
Pharmaceutical Executive® delivers expert insights and analysis on pharma strategy, R&D, and market access—helping executives navigate industry challenges.
Find us at https://www.pharmexec.com/
Find us at https://www.pharmexec.com/
⏰ Time is running out!⏰
We invite you to participate in PE’s 2025 State of the Industry Survey — and share with others! From pricing and policy, to M&A and AI, here’s your chance to weigh in on the trends and changes that matter most to you and the wider pharma enterprise.
We invite you to participate in PE’s 2025 State of the Industry Survey — and share with others! From pricing and policy, to M&A and AI, here’s your chance to weigh in on the trends and changes that matter most to you and the wider pharma enterprise.
State of the Industry Survey
Take this survey powered by surveymonkey.com. Create your own surveys for free.
www.surveymonkey.com
March 6, 2025 at 3:15 PM
⏰ Time is running out!⏰
We invite you to participate in PE’s 2025 State of the Industry Survey — and share with others! From pricing and policy, to M&A and AI, here’s your chance to weigh in on the trends and changes that matter most to you and the wider pharma enterprise.
We invite you to participate in PE’s 2025 State of the Industry Survey — and share with others! From pricing and policy, to M&A and AI, here’s your chance to weigh in on the trends and changes that matter most to you and the wider pharma enterprise.
The recent shift in Health Economics and Outcomes Research functions across major #pharmaceutical companies highlights a lack of understanding of its value.
HEOR: From Proving Product Value to Proving Its Own Worth
The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.
www.pharmexec.com
March 6, 2025 at 1:25 PM
The recent shift in Health Economics and Outcomes Research functions across major #pharmaceutical companies highlights a lack of understanding of its value.
The acquisition is expected to enhance Jazz Pharmaceuticals's #oncology portfolio by adding dordaviprone, a novel small molecule therapy in development for H3 K27M-mutant diffuse glioma.
#pharma #pharmaceutical #mergersandacquisitions #lifesciences
#pharma #pharmaceutical #mergersandacquisitions #lifesciences
Jazz Pharmaceuticals Acquires Chimerix for $935 million
The acquisition is expected to enhance Jazz's oncology portfolio by adding dordaviprone, a novel small molecule therapy in development for H3 K27M-mutant diffuse glioma.
www.pharmexec.com
March 6, 2025 at 1:24 PM
The acquisition is expected to enhance Jazz Pharmaceuticals's #oncology portfolio by adding dordaviprone, a novel small molecule therapy in development for H3 K27M-mutant diffuse glioma.
#pharma #pharmaceutical #mergersandacquisitions #lifesciences
#pharma #pharmaceutical #mergersandacquisitions #lifesciences
New indication for Tevimbra in combination with platinum-containing chemotherapy as a first-line treatment addresses an unmet need for adults with unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1.
#pharma #pharmanews #pharmaceutical #lifesciences
#pharma #pharmanews #pharmaceutical #lifesciences
FDA Approves BeiGene’s Tevimbra for Unresectable or Metastatic Esophageal Squamous Cell Carcinoma
New indication for Tevimbra in combination with platinum-containing chemotherapy as a first-line treatment addresses an unmet need for adults with unresectable or metastatic esophageal squamous cell c...
www.pharmexec.com
March 5, 2025 at 1:30 PM
New indication for Tevimbra in combination with platinum-containing chemotherapy as a first-line treatment addresses an unmet need for adults with unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1.
#pharma #pharmanews #pharmaceutical #lifesciences
#pharma #pharmanews #pharmaceutical #lifesciences
📹 In this video interview, Dr. Hernan Bazan, MD, DFSVS, FACS, CEO of South Rampart Pharma, Inc., discusses his company’s current pipeline.
#pharma #pharmaceutical #lifesciences #painmanagement
#pharma #pharmaceutical #lifesciences #painmanagement
Developing Non-Addictive Pain Medication
Dr. Hernan Bazan, CEO of South Rampart Pharma, discusses his company’s current pipeline.
www.pharmexec.com
March 5, 2025 at 1:28 PM
📹 In this video interview, Dr. Hernan Bazan, MD, DFSVS, FACS, CEO of South Rampart Pharma, Inc., discusses his company’s current pipeline.
#pharma #pharmaceutical #lifesciences #painmanagement
#pharma #pharmaceutical #lifesciences #painmanagement
📹 In this Pharmaceutical Executive video interview, Jennifer Butler, Chief Commercial Officer for Pleio, explores what kind of role #regulatory agencies should play in the battle against #misinformation
#pharma #pharmaceutical #lifesciences
#pharma #pharmaceutical #lifesciences
The Role Regulatory Agencies Should Play in the Battle Against Misinformation
In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, explores what kind of role regulatory agencies should play in the battle against misinformation.
www.pharmexec.com
March 5, 2025 at 1:26 PM
📹 In this Pharmaceutical Executive video interview, Jennifer Butler, Chief Commercial Officer for Pleio, explores what kind of role #regulatory agencies should play in the battle against #misinformation
#pharma #pharmaceutical #lifesciences
#pharma #pharmaceutical #lifesciences
In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, obstruction, and asthma exacerbations compared to placebo.
#pharma #pharmaceutical #clinicaltrials #lifesciences #FDA
#pharma #pharmaceutical #clinicaltrials #lifesciences #FDA
FDA Accepts Biologics License Application for GSK’s Depemokimab for Asthma with Type 2 Inflammation and CRSwNP
In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, obstruction, and asthma exacerbations compared to placebo.
www.pharmexec.com
March 4, 2025 at 1:29 PM
In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, obstruction, and asthma exacerbations compared to placebo.
#pharma #pharmaceutical #clinicaltrials #lifesciences #FDA
#pharma #pharmaceutical #clinicaltrials #lifesciences #FDA
📹 In this part of her Pharmaceutical Executive video interview, Jennifer Butler, Chief Commercial Officer for Pleio, discusses why #pharma increasingly turning to #peertopatient platforms to educate patients, as well as relationships with trusted #patientcommunities and pharmacies.
#pharmaceutical
#pharmaceutical
Pharma’s Turn to Peer-to-Patient Platforms and Trusted Patient Communities
In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, discusses why pharma increasingly turning to peer-to-patient platforms to educate patients, as well as...
www.pharmexec.com
March 4, 2025 at 1:21 PM
📹 In this part of her Pharmaceutical Executive video interview, Jennifer Butler, Chief Commercial Officer for Pleio, discusses why #pharma increasingly turning to #peertopatient platforms to educate patients, as well as relationships with trusted #patientcommunities and pharmacies.
#pharmaceutical
#pharmaceutical
#pharma #pharmaceutical #lifesciences #regulatory #clinicaltrials #clinicalresearch #pharmaceuticalindustry
Pharma Pulse 3/4/25: A New Era for Faster, Smarter Clinical Trials, Educational Resources to Support Patients & more
The latest news for pharma industry insiders.
www.pharmexec.com
March 4, 2025 at 1:14 PM
📹 In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, explores how #tariffs could affect the availability and accessibility of specific medications, particularly for patients relying on direct-to-patient #telehealth
#pharmaceutical #regulatory #pharma
#pharmaceutical #regulatory #pharma
Potential Tariff Impact on Availability & Accessibility of Medications for Telehealth Patients
In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, explores how tariffs could affect the availability and accessibility of specific medications, particularly ...
www.pharmexec.com
March 4, 2025 at 1:13 PM
📹 In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, explores how #tariffs could affect the availability and accessibility of specific medications, particularly for patients relying on direct-to-patient #telehealth
#pharmaceutical #regulatory #pharma
#pharmaceutical #regulatory #pharma
📹 In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, the role #pharma should be playing in helping to ensure patients have access to health insights they can trust.
#pharmaceutical #lifesciences #trustgap #socialmedia #healthliteracy #patientaccess
#pharmaceutical #lifesciences #trustgap #socialmedia #healthliteracy #patientaccess
Pharma’s Role in Ensuring Patient Access to Trustworthy Health Insights
In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, the role pharma should be playing in helping to ensure patients have access to health insights they ca...
www.pharmexec.com
March 3, 2025 at 3:07 PM
📹 In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, the role #pharma should be playing in helping to ensure patients have access to health insights they can trust.
#pharmaceutical #lifesciences #trustgap #socialmedia #healthliteracy #patientaccess
#pharmaceutical #lifesciences #trustgap #socialmedia #healthliteracy #patientaccess
Three of the new sites will focus primarily on producing ingredients for domestic usage.
#pharma #pharmaceutical #lifesciences #tariffs @elilillyandcompany.bsky.social
#pharma #pharmaceutical #lifesciences #tariffs @elilillyandcompany.bsky.social
Eli Lilly Announces Four New Domestic Production Sites
Three of the new sites will focus primarily on producing ingredients for domestic usage.
www.pharmexec.com
March 3, 2025 at 3:05 PM
Three of the new sites will focus primarily on producing ingredients for domestic usage.
#pharma #pharmaceutical #lifesciences #tariffs @elilillyandcompany.bsky.social
#pharma #pharmaceutical #lifesciences #tariffs @elilillyandcompany.bsky.social
📹 Ron Lanton, Partner, Lanton Law, discusses the legal and industry challenges posed by recent National Institute of Health budget cuts, #diversity bans in #clinicaltrials, and #pharmaceutical #supplychain disruptions due to #tariffs.
Navigating NIH Funding Cuts, Diversity Bans, and Tariff Challenges: Legal and Industry Implications for Medical Research
Ron Lanton, Partner, Lanton Law, discusses the legal and industry challenges posed by recent National Institute of Health budget cuts, diversity bans in clinical trials, and pharmaceutical supply cha...
www.pharmexec.com
March 3, 2025 at 3:03 PM
📹 Ron Lanton, Partner, Lanton Law, discusses the legal and industry challenges posed by recent National Institute of Health budget cuts, #diversity bans in #clinicaltrials, and #pharmaceutical #supplychain disruptions due to #tariffs.
📹In this part of his Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, identifies strategies that #pharmaceutical companies and #digitalhealth platforms can employ to navigate a potential drop in demand due to #tariff-induced increased costs.
#tariffs #pharma
#tariffs #pharma
How Pharmaceutical Companies Can Mitigate a Potential Drop in Demand Due to Tariffs
In this part of his Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, identifies strategies that pharmaceutical companies and digital health platforms can employ to ...
www.pharmexec.com
March 3, 2025 at 3:02 PM
📹In this part of his Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, identifies strategies that #pharmaceutical companies and #digitalhealth platforms can employ to navigate a potential drop in demand due to #tariff-induced increased costs.
#tariffs #pharma
#tariffs #pharma
#FDA recently announced new safety requirements for DPD screening in #cancer patients. Kristine Ashcraft, founder and CEO of YouScript, spoke with Pharmaceutical Executive about these updates and the impact it will have on #oncology.
#pharmaceutical #pharma #cancerresearch #lifesciences
#pharmaceutical #pharma #cancerresearch #lifesciences
Screening for DPD: Q&A with Kristine Ashcraft
The YouScript CEO discusses new FDA guidance.
www.pharmexec.com
February 28, 2025 at 2:15 PM
#FDA recently announced new safety requirements for DPD screening in #cancer patients. Kristine Ashcraft, founder and CEO of YouScript, spoke with Pharmaceutical Executive about these updates and the impact it will have on #oncology.
#pharmaceutical #pharma #cancerresearch #lifesciences
#pharmaceutical #pharma #cancerresearch #lifesciences
📹 In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, addresses how #tariffs will affect #pharmaceutical costs and which #drug categories will be most affected.
#pharma #lifesciences #pharmaceuticalindustry #tariff #regulatory
#pharma #lifesciences #pharmaceuticalindustry #tariff #regulatory
How Tariffs Will Drive Up Pharmaceutical Costs & Which Drug Categories Will Be Most Affected
In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, addresses how tariffs will affect pharmaceutical costs and which drug categories will be most affected.
www.pharmexec.com
February 28, 2025 at 2:12 PM
📹 In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, addresses how #tariffs will affect #pharmaceutical costs and which #drug categories will be most affected.
#pharma #lifesciences #pharmaceuticalindustry #tariff #regulatory
#pharma #lifesciences #pharmaceuticalindustry #tariff #regulatory
📹 In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, shares some best practices on finding trustworthy and verified information about a new #prescription or #medicaldevice.
#Pharmaceutical #lifesciences #pharma
#Pharmaceutical #lifesciences #pharma
Verifying Information About New Prescriptions or Medical Devices
In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, shares some best practices on finding trustworthy and verified information about a new prescription o...
www.pharmexec.com
February 28, 2025 at 2:11 PM
📹 In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, shares some best practices on finding trustworthy and verified information about a new #prescription or #medicaldevice.
#Pharmaceutical #lifesciences #pharma
#Pharmaceutical #lifesciences #pharma
Welcome to our 🆕 monthly round up of industry movers and shakers!
At the end of each month Pharmaceutical Executive will be gathering all of the month's business and people news in one place for you to easily click through and stay up-to-date on what's happening in the #pharmaceutical industry.
At the end of each month Pharmaceutical Executive will be gathering all of the month's business and people news in one place for you to easily click through and stay up-to-date on what's happening in the #pharmaceutical industry.
Pharmaceutical Industry Movers & Shakers
A monthly roundup of business and people news in the pharmaceutical industry.
www.pharmexec.com
February 28, 2025 at 2:10 PM
Welcome to our 🆕 monthly round up of industry movers and shakers!
At the end of each month Pharmaceutical Executive will be gathering all of the month's business and people news in one place for you to easily click through and stay up-to-date on what's happening in the #pharmaceutical industry.
At the end of each month Pharmaceutical Executive will be gathering all of the month's business and people news in one place for you to easily click through and stay up-to-date on what's happening in the #pharmaceutical industry.
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real-time brain activity to improve #Parkinson disease symptom control without manual adjustments.
#pharma #pharmaceutical #pharmanews #lifesciences #FDAapproved #regulatory #FDA
#pharma #pharmaceutical #pharmanews #lifesciences #FDAapproved #regulatory #FDA
FDA Approves Medtronic’s BrainSense Adaptive Deep Brain Stimulation for Parkinson Disease
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real-time brain activity to improve Parkinson disease symptom control without m...
www.pharmexec.com
February 25, 2025 at 1:31 PM
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real-time brain activity to improve #Parkinson disease symptom control without manual adjustments.
#pharma #pharmaceutical #pharmanews #lifesciences #FDAapproved #regulatory #FDA
#pharma #pharmaceutical #pharmanews #lifesciences #FDAapproved #regulatory #FDA
In this Q&A, Organon's Chief Communications Officer, Rebecca Lowell Edwards discusses how much #socialmedia and #influencers sway decisions about #birthcontrol methods, potential consequences of these misinformed choices, and more.
#pharma #pharmaceutical #lifesciences #fertility #misinformation
#pharma #pharmaceutical #lifesciences #fertility #misinformation
Social Media's Influence on Young Women's Reproductive Decisions
In this Q&A, Organon's Chief Communications Officer, Becky Edwards discusses how much social media and influencers sway decisions about birth control methods, potential consequences of these misinform...
www.pharmexec.com
February 25, 2025 at 1:29 PM
In this Q&A, Organon's Chief Communications Officer, Rebecca Lowell Edwards discusses how much #socialmedia and #influencers sway decisions about #birthcontrol methods, potential consequences of these misinformed choices, and more.
#pharma #pharmaceutical #lifesciences #fertility #misinformation
#pharma #pharmaceutical #lifesciences #fertility #misinformation
A look at the #M&A and #stockmarket pictures for full-year 2024—and the potential strategic implications for #pharma and #biotech ahead.
#pharmaceutical #biotechnology #lifsciences #finance #mergersandacquisitions
#pharmaceutical #biotechnology #lifsciences #finance #mergersandacquisitions
Biopharma Business Check: Financing Review and Outlook
A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and biotech ahead.
www.pharmexec.com
February 24, 2025 at 7:36 PM
A look at the #M&A and #stockmarket pictures for full-year 2024—and the potential strategic implications for #pharma and #biotech ahead.
#pharmaceutical #biotechnology #lifsciences #finance #mergersandacquisitions
#pharmaceutical #biotechnology #lifsciences #finance #mergersandacquisitions
How one #BigPharma ad campaign is incorporating #diversity as a driving force in improving the ways drugs are marketed directly to the patients that need them.
#pharmaceuticalmarketing #lifesciences #pharmaceutical #marketing #pharma #deandi #de&i #patientengagement
#pharmaceuticalmarketing #lifesciences #pharmaceutical #marketing #pharma #deandi #de&i #patientengagement
Inclusive Marketing: Engaging with Purpose
How one Big Pharma ad campaign is incorporating diversity as a driving force in improving the ways drugs are marketed directly to the patients that need them.
www.pharmexec.com
February 24, 2025 at 7:34 PM
How one #BigPharma ad campaign is incorporating #diversity as a driving force in improving the ways drugs are marketed directly to the patients that need them.
#pharmaceuticalmarketing #lifesciences #pharmaceutical #marketing #pharma #deandi #de&i #patientengagement
#pharmaceuticalmarketing #lifesciences #pharmaceutical #marketing #pharma #deandi #de&i #patientengagement
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in #socialmedia will impact industry #marketing strategies and the relationships between #pharmaceutical companies and patients. He also explains #darksocial, how to combat #misinformation, closing the #trustgap, and more.
Navigating Distrust: Pharma in the Age of Social Media
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients...
www.pharmexec.com
February 24, 2025 at 3:30 PM
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in #socialmedia will impact industry #marketing strategies and the relationships between #pharmaceutical companies and patients. He also explains #darksocial, how to combat #misinformation, closing the #trustgap, and more.